Researchers at the University of Manitoba – Winnipeg and St. Boniface Hospital in Winnipeg have published the results of their research into a new antibiotic compound. This compound, referred to as PEG-2s, is novel in the way it ‘attacks’ infecting bacteria. Traditional antibiotics usually target a bacteria cell’s cell wall or its processes of DNA replication and protein synthesis. PEG-2s instead takes aim at one particular protein that is responsible for providing energy to the cell. The compound is so accurate and effective that the researchers claim that it does not have an effect on good gut bacteria or the body’s…